Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Seth P Lerner

Showing results (71-80 of 294) with videos related to

Pageof 30
Sort By:
Urologic Oncology|February 4, 2010
Overview of SUO Winter 2008 proceedingsSeth P Lerner, Bernard Bochner, W Marston Linehan, et al.
Molecular Cancer Therapeutics|June 11, 2009
Enzastaurin shows preclinical antitumor activity against human transitional cell carcinoma and enhances the activity of gemcitabineWeiguo Jian, Hideyuki Yamashita, Jonathan M Levitt, et al.
Urology|July 5, 2008
Optical coherence tomography as an adjunct to white light cystoscopy for intravesical real-time imaging and staging of bladder cancerAlvin C Goh, Nancy J Tresser, Steven S Shen, et al.
European Urology Focus|September 11, 2018
Background and Update for S1602 "A Phase III Randomized Trial to Evaluate the Influence of BCG Strain Differences and T Cell Priming with Intradermal BCG Before Intravesical Therapy for BCG-naïve High-grade Non-muscle-invasive Bladder CancerRobert S Svatek, Cathy Tangen, Scott Delacroix, et al.
Urology|June 18, 2003
Association of p53 and p21 expression with clinical outcome in patients with carcinoma in situ of the urinary bladderShahrokh F Shariat, JaHong Kim, Grigorios Raptidis, et al.
Nature Reviews. Urology|April 11, 2012
Perioperative chemotherapy for upper tract urothelial cancerAjjai S Alva, Surena F Matin, Seth P Lerner, et al.
Urologic Oncology|March 28, 2008
Failure to achieve a complete response to induction BCG therapy is associated with increased risk of disease worsening and death in patients with high risk non-muscle invasive bladder cancerSeth P Lerner, Catherine M Tangen, Heidi Sucharew, et al.
The Journal of Urology|April 18, 2007
Patterns of recurrence and outcomes following induction bacillus Calmette-Guerin for high risk Ta, T1 bladder cancerSeth P Lerner, Catherine M Tangen, Heidi Sucharew, et al.
The Journal of Urology|April 13, 2004
Stage specific lymph node metastasis mapping in radical cystectomy specimensAmnon Vazina, Daniel Dugi, Shahrokh F Shariat, et al.
Expert Opinion on Pharmacotherapy|July 17, 2008
Neoadjuvant chemotherapy preceding cystectomy for bladder cancerGuru Sonpavde, Gilad E Amiel, Martha P Mims, et al.
Pageof 30

Showing results (71-80 of 294) with videos related to

Sort By:
Pageof 30
Urologic Oncology|February 4, 2010
Overview of SUO Winter 2008 proceedingsSeth P Lerner, Bernard Bochner, W Marston Linehan, et al.
Molecular Cancer Therapeutics|June 11, 2009
Enzastaurin shows preclinical antitumor activity against human transitional cell carcinoma and enhances the activity of gemcitabineWeiguo Jian, Hideyuki Yamashita, Jonathan M Levitt, et al.
Urology|July 5, 2008
Optical coherence tomography as an adjunct to white light cystoscopy for intravesical real-time imaging and staging of bladder cancerAlvin C Goh, Nancy J Tresser, Steven S Shen, et al.
European Urology Focus|September 11, 2018
Background and Update for S1602 "A Phase III Randomized Trial to Evaluate the Influence of BCG Strain Differences and T Cell Priming with Intradermal BCG Before Intravesical Therapy for BCG-naïve High-grade Non-muscle-invasive Bladder CancerRobert S Svatek, Cathy Tangen, Scott Delacroix, et al.
Urology|June 18, 2003
Association of p53 and p21 expression with clinical outcome in patients with carcinoma in situ of the urinary bladderShahrokh F Shariat, JaHong Kim, Grigorios Raptidis, et al.
Nature Reviews. Urology|April 11, 2012
Perioperative chemotherapy for upper tract urothelial cancerAjjai S Alva, Surena F Matin, Seth P Lerner, et al.
Urologic Oncology|March 28, 2008
Failure to achieve a complete response to induction BCG therapy is associated with increased risk of disease worsening and death in patients with high risk non-muscle invasive bladder cancerSeth P Lerner, Catherine M Tangen, Heidi Sucharew, et al.
The Journal of Urology|April 18, 2007
Patterns of recurrence and outcomes following induction bacillus Calmette-Guerin for high risk Ta, T1 bladder cancerSeth P Lerner, Catherine M Tangen, Heidi Sucharew, et al.
The Journal of Urology|April 13, 2004
Stage specific lymph node metastasis mapping in radical cystectomy specimensAmnon Vazina, Daniel Dugi, Shahrokh F Shariat, et al.
Expert Opinion on Pharmacotherapy|July 17, 2008
Neoadjuvant chemotherapy preceding cystectomy for bladder cancerGuru Sonpavde, Gilad E Amiel, Martha P Mims, et al.
Pageof 30